1 / 16

Psychotropics (“ moving closer to a normal state”) trop – to turn toward

Psychotropics (“ moving closer to a normal state”) trop – to turn toward. Drugs for treating schizophrenia and Mood Disorders. THE BIOMEDICAL MODEL OF MENTAL ILLNESS. Mental disorders are caused by abnormal biochemical processes in the brain. Genetic evidence for the biomedical model.

carla-schultz
Download Presentation

Psychotropics (“ moving closer to a normal state”) trop – to turn toward

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Psychotropics(“moving closer to a normal state”)trop – to turn toward Drugs for treating schizophrenia and Mood Disorders

  2. THE BIOMEDICAL MODEL OF MENTAL ILLNESS • Mental disorders are caused by abnormal biochemical processes in the brain. • Genetic evidence for the biomedical model

  3. SYMPTOMS OF SCHIZOPHRENIA Schizophrenic patients are “split off” or “broken off” from a firm sense of reality. positive symptoms of schizophrenia: delusional thinking, hallucinations (usually auditory), dulled emotions, inappropriate verbal expressions, odd body postures (catatonia).

  4. ANTIPSYCHOTIC DRUG TREATMENT • First-generation antipsychotic drugs: Thorazine, Haldol, Mellaril, Stelazine • Second-generation antipsychotic drugs: Clozaril, Zyprexa, Risperdal • Third-generation antipsychotic drugs: Abilify

  5. SIDE EFFECTS OF ANTIPSYCHOTIC DRUGS • First-generation drugs: Parkinson-like symptoms, tardive dyskinesia • Clozaril: Agranulocytosis in 1-2 percent of patients • Zyprexa and Risperdal: Significant weight gain and development of diabetes, dementia among elderly patients

  6. ANTIPSYCHOTIC DRUGS AND THE BRAIN • In general, antipsychotic drugs are altering the level of stimulation of dopamine-sensitive receptors in the brain. • Subtypes of dopamine-sensitive receptors are differentially affected by various antipsychotic drugs. • Third-generation antipsychotic drugs stabilize (modulate) the level of D2 receptors

  7. Psychiatrists, Children and Drug Industry’s Role By GARDINER HARRIS, BENEDICT CAREY and JANET ROBERTS Published: May 10, 2007 “When Anya Bailey developed an eating disorder after her 12th birthday, her mother took her to a psychiatrist at the University of Minnesota who prescribed a powerful antipsychotic drug called Risperdal.” http://www.nytimes.com/2007/05/10/health/10psyche.html?fta=y

  8. “In 2006, the Food and Drug Administration received reports of at least 29 children dying and at least 165 more suffering serious side effects in which an antipsychotic was listed as the “primary suspect.” That was a substantial jump from 2000, when there were at least 10 deaths and 85 serious side effects among children linked to the drugs. Since reporting of bad drug effects is mostly voluntary, these numbers likely represent a fraction of the toll.” http://www.nytimes.com/2007/05/10/health/10psyche.html?pagewanted=4&fta=y

  9. Poor Children Likelier to Get Antipsychotics DUFF WILSON Published: December 11, 2009 Dr. Derek H. Suite, a psychiatrist in the Bronx, says he sees many children on antipsychotic drugs who do not need them. http://www.nytimes.com/2009/12/12/health/12medicaid.html?em

  10. ANTIDEPRESSANT DRUGS • First-generation antidepressant drugs: MAO-inhibitors (Nardil, Parnate), tricyclic drugs (Tofranil, Elavil) • Second-generation antidepressant drugs: SSRIs (Prozac, Celexa, Paxil, Zoloft) • Third-generation antidepressant drugs: Cymbalta, Remeron, Effexor

  11. ANTIDEPRESSANTS AND NEUROTRANSMITTERS • MAO-inhibitors raise functioning levels of norepinephrine and serotonin. • SSRIs raise functioning levels of serotonin. • Third-generation antidepressants raise functioning levels of norepinephrine and serotonin.

  12. DRUGS FOR OTHER TYPES OF MENTAL DISORDERS Mania and bipolar disorders: Lithium, Depakote, Symbyax, Abilify Autism: Risperdal Mild depression: St. John’s wort

  13. ISSUES IN MENTAL HEALTH TREATMENT • Social effects of deinstitutionalization • Psychiatric drugs and civil liberties • Impact of health insurance coverage policy

  14. http://www.crazymeds.us/pmwiki/pmwiki.php/Main/HomePage

  15. www.forumsextreme.com/imgs1/Funny_Pictures_Ge...

More Related